Influential analysis has concluded that "breakthrough" Alzheimer's drugs are unlikely to benefit patients.
Researchers said the impact was "well below" what was needed to make a difference to dementia patients' lives.
However, their report has also provoked a vicious backlash from equally esteemed scientists who label it as fundamentally flawed.
Subscribe to our channel here: https://bbc.in/bbcnews
For the latest news download the BBC News app or visit BBC.com/news
#BBCNews
Alzheimer's Breakthrough Drugs Questioned
- Dementia drugs hailed as 'beginning of the end' for Alzheimer's do not work, major report finds Daily Mail —
- Alzheimer's drugs make 'no meaningful difference' RTE —
- 'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests BBC News —
- Much-hyped Alzheimer’s drugs do not help patients, review finds The Straits Times —
- The surprising value of boring chats, ‘super El Niño’ and Alzheimer’s evidence reviewed – podcast The Guardian —
'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests | BBC News
BBC News
—